(Total Views: 333)
Posted On: 10/15/2025 6:14:22 PM
Post# of 158065
Quote:
So treatment should be given when needed..no need to withhold for a year..
Agreed, but that's up to the FDA and given when the company must have first known about the leronlimab/PD-L1 inhibitor connection I believe the company already tried to amend. The fallback position is the DSMB.
(8)
(0)
